Literature DB >> 20696621

Hormonal alterations following seizures.

Gerhard Luef1.   

Abstract

Postictal increases in prolactin (PRL), luteinizing hormone, and follicle-stimulating hormone have been recorded in patients with both generalized tonic-clonic and partial seizures. Elevations of PRL and luteinizing hormone were seen immediately and at 20 minutes after generalized tonic-clonic seizures in male and female patients. Usually, PRL blood levels return to normal values within 1 hour. Previous studies have evaluated the utility of the transient increases in PRL, neuron-specific enolase, and S-100 protein as markers of epileptic seizures in children and adults. The conclusion was that measurement of serum PRL is a reliable confirmatory test in the presence of a seizure, but only modestly effective as a screening test for suspected seizures. Temporal lobe epilepsy is associated with abnormalities of reproductive physiology, but the mechanisms of hormonal dysregulation are not clear. A direct influence of epilepsy on the reproductive endocrine system is suggested by acute changes in PRL and gonadotropin levels following generalized and partial seizures, pointing to a possible relationship between temporolimbic epileptiform discharges and particular reproductive endocrine disorders. Chronic effects of the epileptic state and the acute impact of seizures could alter hypothalamic function, as indicated by downstream pulsatile secretion of luteinizing hormone. The brain controls reproductive function primarily through hypothalamic regulation of pituitary secretion regions of the hypothalamus. These are areas that are involved in the regulation, production, and secretion of gonadotropin-releasing hormone and receive extensive direct connections from the cerebral hemispheres, especially from temporolimbic structures, most notably from the amygdala, that are commonly involved in temporal lobe epilepsy. Significant relationships have been uncovered through which ictal and postictal effects of seizures and epilepsy may influence the function of this complex neuroendocrine system.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696621     DOI: 10.1016/j.yebeh.2010.06.026

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  7 in total

Review 1.  Childhood epilepsy and sleep.

Authors:  Mohammed A Al-Biltagi
Journal:  World J Clin Pediatr       Date:  2014-08-08

Review 2.  Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?

Authors:  John J Craig
Journal:  Obstet Med       Date:  2012-02-20

3.  Altered S100 Calcium-Binding Protein B and Matrix Metallopeptidase 9 as Biomarkers of Mesial Temporal Lobe Epilepsy with Hippocampus Sclerosis.

Authors:  Nagwa A Meguid; Hatem Samir; Geir Bjørklund; Mona Anwar; Adel Hashish; Farouk Koura; Salvatore Chirumbolo; Saher Hashem; Mona A El-Bana; Hebatalla S Hashem
Journal:  J Mol Neurosci       Date:  2018-10-20       Impact factor: 3.444

4.  Seizure duration may increase thyroid-stimulating hormone levels in children experiencing a seizure.

Authors:  Ji Yoon Han; In Goo Lee; Soyoung Shin; Joonhong Park
Journal:  J Int Med Res       Date:  2019-11-27       Impact factor: 1.671

Review 5.  Research Progress on the Effect of Epilepsy and Antiseizure Medications on PCOS Through HPO Axis.

Authors:  Shuang Li; Linhai Zhang; Nian Wei; Zhenzhen Tai; Changyin Yu; Zucai Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-21       Impact factor: 5.555

6.  General seizures revealing macro-adenomas secreting prolactin or prolactin and growth hormone in men.

Authors:  Farida Chentli; Lina Akkache; Katia Daffeur; Said Azzoug
Journal:  Indian J Endocrinol Metab       Date:  2014-05

7.  A Comparative Study of the Effects of Valproate and Oxcarbazepine on Sexual Function, Sperm Quality, and Sex Hormones in Males with Epilepsy.

Authors:  Yi Guo; Lang Chen; Dongmei Wu; Liang Yu; Hongbin Sun; Qiong Zhu
Journal:  Biomed Res Int       Date:  2021-07-03       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.